Helix Fund
Investing for the Future
The Helix Fund, established in 2010, is St. Louis County’s Investment Fund to provide seed capital to early-stage startups. Referrals for investment generally come through trusted partners, and the Helix Fund requires all companies that receive funding to locate in St. Louis County. The maximum level of investment is $250,000. In addition, all investments are equity-based.
Below is a portfolio list of companies that have received funding from the Helix Fund investments:
- Apse
- Arvegenix
- Benson Hill Biosystems
- Better Weekdays
- Confluence Life Sciences *
- Electrochaea
- Elira Therapeutics
- Euclises Pharmaceuticals
- Graematter
- Immunophotonics
- Kultevat
- MediBeacon
- Plastomics
- Prosper Capital
- Pushup Social
- S4 AgTech
- SynerZ Medical **
- Terra Biologics
- Traxxsson
- Yield Lab – Fund 1
* = Confluence Life Sciences was acquired by Aclaris Therapeutics in August 2017 for $100M.
** = SynerZ Medical was acquired by W.L. Gore & Associates in August 2016 for $10M.